Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL

by | Dec 15, 2022 | Publications

Blood Adv. 2022 Dec 14:bloodadvances.2022008362. doi: 10.1182/bloodadvances.2022008362. Online ahead of print.

NO ABSTRACT

Decoding pathogenesis factors

Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a...

HTLV-1 Disease Abstract The years 2020 and 2021 will remain memorable years for many reasons [...]. Click here to...

HTLV-2 Encoded Antisense Protein APH-2 Suppresses HIV-1 Replication Abstract Antisense protein of Human T-cell...

Generated by Feedzy